Skip to main content

Table 1 Demographic and clinical data for the 20 representative patients included in the study

From: High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis

Patient number

Age (years)

F/M

Duration of disease (years)

Source of synovial tissue

CRP (mg/l)

RF

DMARDs

NSAIDs

Corticosteroid

Rheumatoid arthritis patients

       

1

32

M

5

TJR, knee joint left

82.7

+

+

-

+

2

49

F

6

Expiration baker cystis, knee joint right

32.5

+

+

-

+

3

73

M

10

TJR, knee joint right

74.8

+

-

+

-

4

65

F

16

TJR, thigh joint right

29.5

?

+

+

+

5

60

M

9

SE, knee joint right

84.6

+

-

+

-

6

55

F

10

TJR, knee joint right

62.2

-

-

+

-

7

57

F

10

TJR, knee joint left

17.4

+

-

+

+

8

55

M

10

TJR, knee joint left

49.5

-

-

+

-

9

46

M

8

SE, wrist joint left

15.9

+

+

-

-

10

49

F

12

SE, wrist joint right

40.7

+

+

+

-

Osteoarthritis patients

       

1

52

M

2

SE, knee joint left

96.0

-

-

-

-

2

31

F

5

SE, knee joint left

36.0

+

-

-

-

3

37

M

1

SE, knee joint right

<5.0

-

-

-

-

4

70

M

5

TJR, knee joint right

<5.0

-

-

+

-

5

77

M

8

TJR, knee joint right

<5.0

-

-

+

-

6

62

F

16

TJR, knee joint right

<5.0

-

-

+

-

7

74

F

20

TJR, knee joint left

<5.0

-

-

+

-

8

69

F

10

TJR, knee joint right

12.2

?

-

+

-

9

71

F

10

TJR, knee joint left

15.9

+

-

+

-

10

67

F

1.5

TJR, knee joint left

<5.0

-

-

+

-

  1. CRP, C-reactive protein; DMARD, disease-modifying antirheumatic drug; F/M, female/male; NSAID, nonsteroidal anti-inflammatory drug; RF, rheumatoid factor; SE, synovectomy; TJR, total joint replacement.